Telomere shortening and apoptosis in telomerase-inhibited human tumor cells

Genes and Development

Volumn 13, Issue 18, 1999, Pages 2388-2399

  Zhang, Xiaoling ^a   Mar, Vernon ^a   Zhou, Wen ^a   Harrington, Lea ^b   Robinson, Murray O ^a  

^a Department of Cancer Biology ^*  (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cancer; Dominant negative; Proliferation; Telomere; TERT

Indexed keywords

TELOMERASE;

ANAPHASE; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL KINETICS; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TELOMERE; TUMOR CELL;

APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENES, DOMINANT; HUMANS; MITOSIS; MUTAGENESIS; RNA; TELOMERASE; TELOMERE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033568462     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.18.2388     Document Type: Article

References (40)

1. Beattie, T.L., W. Zhou, M.O. Robinson, and L. Harrington. 1998. Reconstitution of human telomerase activity in vitro. Curr. Biol. 8: 177-180.
2. Blasco, M.A., H.W. Lee, M.P. Hande, E. Samper, P.M. Lansdorp, R.A. DePinho, and C.W. Greider. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
3. Bodnar, A.G., M. Ouellette, M. Frolkis, S.E. Holt, C.P. Chiu, G.B. Morin, C.B. Harley, J.W. Shay, S, Lichtsteiner, and W.E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
4. Bryan, T.M. and R.R. Reddel. 1997. Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur. J. Cancer 33: 767-773.
5. Bryan, T.M., J.M. Sperger, K.B. Chapman, and T.R. Cech. 1998. Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax. Proc. Natl. Acad. Sci. 95: 8479-8484.
6. Chin, L., S.E. Artand, Q. Shen, A. Tam, S.L. Lee, G.J. Gottlieb, C.W. Greider, and R.A. DePinho. 1999. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomerase dysfunction to accelerate carcinogenesis. Cell 97: 527-538.
7. Collins, K. and L. Gandhi. 1998. The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex. Proc. Natl. Acad. Sci. 95: 8485-8490.
8. Collins, K., R. Kobayashi, and C.W. Greider. 1995. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 81: 677-686.
9. Counter, C.M., A.A. Avilion, C.E. LeFeuvre, N.G. Stewart, C.W. Greider, C.B. Harley, and S. Bacchetti. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO. J. 11: 1921-1929.
10. Counter, C.M., M. Meyerson, E.N. Eaton, and R.A. Weinberg. 1997. The catalytic subunit of yeast telomerase. Proc. Natl. Acad. Sci. 94: 9202-9207.
11. Fadok, V.A., D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207-2216.
12. Greenberg, R.A., R.C. Allsopp, L. Chin, G.B. Morin, and R.A. DePinho. 1998. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16: 1723-1730.
13. Greenberg, R.A., L. Chin, A. Femino, K.H. Lee, G.J. Gottlieb, R.H. Singer, C.W. Greider, and R.A. DePinho. 1999. Short dysfunctional telomeres impair tumorigenesis in the INK4a2/3 cancer-prone mouse. Cell 97: 515-525.
14. Greider, C.W. 1996. Telomere length regulation. Annu. Rev. Biochem. 65: 337-365.
15. _. 1998. Telomeres and senescence: The history, the experiment, the future. Curr. Biol. 8: 178-181.
16. Harley, C.B. 1991. Telomere loss: Mitotic clock or genetic time bomb? Mutat. Res. 256: 271-282.
17. Harley, C.B. and S.W. Sherwood. 1997. Telomerase, checkpoints and cancer. Cancer. Surv. 29: 263-284.
18. Harley, C.B., A.B. Futcher, and C.W. Greider. 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460.
19. Harrington, L., T. McPhail, V. Mar, W. Zhou, R. Oulton, M.B. Bass, I. Arruda, and M.O. Robinson. 1997a. A mammalian telomerase-associated protein. Science 275: 973-977.
20. Harrington, L., W. Zhou, T. McPhail, R. Oulton, D.S. Yeung, V. Mar, M.B. Bass, and M.O. Robinson. 1997b. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes. & Dev. 11: 3109-3115.
21. Hayflick, L. 1961. The limited in vitro lifetime of human diploid strains. Exp. Cell Res. 25: 614-636.
22. Karlseder, J., D. Broccoli, Y. Dai, S. Hardy, and T. DeLange. 1999. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321-1325.
23. Kilian, A., D.D. Bowtell, H.E. Abud; G.R. Hime, D.J. Venter, P.K. Keese, E.L. Duncan, R.R. Reddel, and R.A. Jefferson. 1997. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6: 2011-2019.
24. Kondo, S., Y. Tanaka, Y. Kondo, M. Hitomi, G.H. Barnett, Y. Ishizaka, J. Liu, T. Haqqi, A. Nishiyama, B. Villeponteau et al. 1998a. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation. FASEB J. 12: 801-811.
25. Kondo, S., Y. Kondo, G.Y. Li, R.H. Silverman, and J.K. Cowell. 1998b. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 16: 3323-3330.
26. Kondo, Y., S. Kondo, Y. Tanaka, T. Haqqi, B.P. Barna, and J.K. Cowell. 1998. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16: 2243-2248.
27. Lee, H.W., M.A. Blasco, G.J. Gottlieb, J.W. Horner, C.W. Greider, and R.A. DePinho. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574.
28. Lendvay, T.S., D.K. Morris, J. Sah, B. Balasubramanian, and V. Lundblad. 1996. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144: 1399-1412.
29. Lingner, J., T.R. Hughes, A. Shevchenko, M. Mann, V. Lundblad, and T.R. Cech. 1997. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276: 561-567.
30. Lundblad, V. 1997. The end replication problem: More than one solution. Nat. Med. 3: 1198-1199.
31. Lundblad, V. and J. W. Szostak. 1989. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57: 633-643.
32. Meyerson, M., C.M. Counter, E.N. Eaton, L.W. Ellisen, P. Steiner, S.D. Caddle, L. Ziaugra, R.L. Beijersbergen, M.J. Davidoff, Q. Liu et al. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795.
33. Nakamura, T.M., G.B. Morin, K.B. Chapman, S.L. Weinrich, W.H. Andrews, J. Lingner, C.B. Harley, and T.R. Cech. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959.
34. Nakayama, J., M. Saito, H. Nakamura, A. Matsuura, and F. Ishikawa. 1997. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875-884.
35. Nakayama, J., H. Tahara, E. Tahara, M. Saito, K. Ito, H. Nakamura, T. Nakanishi, E. Tahara, T. Ide, and F. Ishikawa. 1998. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18: 65-68.
36. Niida, H., T. Matsumoto, H. Satoh, M. Shiwa, Y. Tokutake, Y. Furuichi, and Y. Shinkai. 1998. Severe growth defect in mouse cells lacking the telomerase RNA component. Nat. Genet. 19: 203-206.
37. Shay, J.W. and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33: 787-791.
38. Vaziri, H. and S. Benchimol. 1998. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8: 279-282.
39. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reuteling-sperger. 1995. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Meth. 184: 39-51.
40. Weinrich, S.L., R. Pruzan, L. Ma, M. Ouellette, V.M. Tesmer, S.E. Holt, A.G. Bodnar, S. Lichtsteiner, N.W. Kim, J.B. Trager et al. 1997. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17: 498-502.